Doxorubicin - CAS 23214-92-8
Not Intended for Therapeutic Use. For research use only.
Category:
ADCs
Product Name:
Doxorubicin
Catalog Number:
23214-92-8
Synonyms:
Adriamycin
CAS Number:
23214-92-8
Description:
Doxorubicin(Adriamycin) is an antibiotic agent that inhibits DNA topoisomerase II and induces DNA damage and apoptosis.
Molecular Weight:
543.52
Molecular Formula:
C27H29NO11
COA:
Inquire
MSDS:
Inquire
Tag:
ADCs Cytotoxin
Chemical Structure
CAS 23214-92-8 Doxorubicin

Related ADCs Cytotoxin Products


M2-Nitrodienamine

Nitrodienamine, an inhibitor of Ca2+/Mg2+ ATPase.

Maytansinoid DM4
(CAS: 799840-96-3)

DM4 is a cytotoxic agent. It is used as the cytotoxic component in antibody-drug conjugates.

CAS 1415246-68-2 MMAF Hydrochloride

MMAF Hydrochloride
(CAS: 1415246-68-2)

Monomethylauristatin F Hcl(MMAF Hcl) is an antitubulin agent that inhibit cell division by blocking the polymerization of tubulin; lower cytotoxic activity than...

Calicheamicin
(CAS: 108212-75-5)

Calicheamicin is a potent DNA-binding cytotoxic antibiotic.Calicheamicin being the most notable enediyne antitumor antibiotics derived from the bacterium Microm...

CAS 87777-29-5 Morphiceptin

Morphiceptin
(CAS: 87777-29-5)

Morphiceptin is a four amino acid peptide derived from the ß-casomorphin, a protein fragment itself derived from the digestion of milk protein casein. It is one...

CAS 224790-71-0 Etbicythionat

Etbicythionat
(CAS: 224790-71-0)

GABA receptor antagonist

CAS 11087-94-8 Tadjakonine

Tadjakonine
(CAS: 11087-94-8)

C20-diterpenoid alkaloid , from the Ranunculaceae family,an antiarrhythmic.

CAS 158440-71-2 Irofulven

Irofulven
(CAS: 158440-71-2)

Irofulven is a semisynthetic sesquiterpene derivative of illudin S, a natural toxin isolated from the fungus Omphalotus illudens. Irofulven alkylates DNA and pr...

CAS 85079-48-7 Brevetoxin PbTx-3

Brevetoxin PbTx-3
(CAS: 85079-48-7)

An activator of voltage-sensitive Na+ channels, a suite of cyclic polyether compounds produced naturally by a species of dinoflagellate known as Karenia brevis....

CAS 6659-51-4 Quireston

Quireston
(CAS: 6659-51-4)

Synthetic, a potent inhibitor of high-affinity choline uptake (HAChU) in synaptosomes.

CAS 145808-47-5 Margatoxin

Margatoxin
(CAS: 145808-47-5)

Margatoxin (MgTx) is a component of the venom of Scorpio Centruroides margaritatus. Margatoxin preferentially inhibits voltage-dependent potassium channels Kv1....

CAS 19918-85-5 Diplacine

Diplacine
(CAS: 19918-85-5)

Diplacine is a nicotinic cholinoreceptor antagonist at the neuromuscular junction.

Olitoriside
(CAS: 13289-20-8)

Extrat from the seeds of Corchorus olitoriu, a cardiac Glycoside.

CAS 40819-78-1 Methyllycaconitine Perchlorate

Methyllycaconitine Perchlorate
(CAS: 40819-78-1)

Potent antagonist for α7-containing neuronal nicotinic receptors (Ki = 1.4 nM). Interacts with α4β2 and α6β2 receptors at concentrations > 40 nM. Attenuates MET...

CAS 345-78-8 Pseudoephedrine Hydrochloride

Pseudoephedrine Hydrochloride
(CAS: 345-78-8)

alpha and beta Adrenoreceptors subtypes agonist; MAO inhibitor. Alkaloid derivative of (+)-Pseudoephedrine from plants of the Ephedra genus, Ephedraceae.

CAS 21829-25-4 Nifedipine

Nifedipine
(CAS: 21829-25-4)

Used as an antihypertensive and antianginal. A dihydorpyridine calcium channel blocker.

Fisonate
(CAS: 132742-32-6)

An inhibitor of serine proteinases of broad spectrum.

FSP-1

Anticoagulant: irreversible inhibitor of serine proteinase a-thrombine. Fluorocontaining phosphonate, identifies an inflammatory subpopulation of macrophages in...

Anhydroperforine
(CAS: 22952-50-7)

Anhydroperforine from the seeds of Haplophyllum perforatum.

CAS 826-36-8 Tempidone

Tempidone
(CAS: 826-36-8)

Potent ganglioblocker, a neuronal nicotinic AChR antagonist. .

Reference Reading


1. Multiwalled carbon nanotube–doxorubicin supramolecular complexes for cancer therapeutics
Hanene Ali-Boucetta, Khuloud T. Al-Jamal, Kostas Kostarelos*. Chem. Commun., 2008, 459–461
In this communication, we describe a previously unreported non-covalent multiwalled nanotube (MWNT)–doxorubicin supra-molecular complex that can be developed for cancer therapy. We have investigated the ability of doxorubicin to interact non-covalently with very thin, pristine MWNT 1 at various mass ratios and evaluated their capability to kill human breast cancer cells. Doxorubicin belongs to a clinically-used family of anthracyclines, therefore constitutes one of the best candidates to test non-covalent complexation with MWNTs. Moreover, doxorubicin 3 is a fluorescent molecule with a chromophore composed of three planar and aromatic hydroxyanthraquinonic rings that are used to monitor its supramolecular interaction with MWNTs. MWNTs were dispersed in water using the tri-block copolymer.
2. Synthesis, in vitro and in vivo anticancer activity of novel 1-(4-imino-1-substituted-1H-pyrazolo[3,4-d] pyrimidin-5(4H)-yl)urea derivatives
Chandra Bhushan Mishra, Raj Kumar Mongre, Shikha Kumari, Dong Kee Jeong* and Manisha Tiwari*. RSC Adv.,2016, 6, 24491–24500
To study apoptosis by flow cytometer, A549 cells were treated with CBS-1 (5 μM and 10 μM) and doxorubicin (10 μM) for 24 h. In result, CBS-1 at 10 μM concentration showed significant (p <0.05) apoptosis against A549 cells and it was found better than doxorubicin (10 μM) as shown in Fig. 6 and Table 3. Result points out that CBS-1 (10 μM) showed 50.98% apoptosis and while doxorubicin (10 mM) displayed 22.74% apoptosis in 24 h. Thus, Hoechst 33342 staining and flow cytometry studies evidently indicate that CBS-1 (10 mM) showed better apoptosis against A549 cells as compared to doxorubicin.
3. Multifunctional ATRP based pH responsive polymeric nanoparticles for improved doxorubicin chemotherapy in breast cancer by proton sponge effect/endo-lysosomal escape
Shantanu V. Lale, Arun Kumar, Farhat Naz, Alok C. Bharti and Veena Koul*. Polym. Chem.,2015, 6,2115–2132
Polymer nanoparticles (NPs) for doxorubicin delivery in breast cancer have been investigated by many researchers to overcome the cardiotoxicity, non-specificity and acquired resistance of cancer cells to current doxorubicin chemotherapy. Polymeric nanoparticles help to improve the bioavailability of doxorubicin by passive targeting of tumors via an enhanced permeation and retention (EPR) effect, by increasing the circulation half-life of doxorubicin and by overcoming acquired cancer cell resistance. These polymeric nanosystems suffer from few drawbacks, which lead to a decreased antitumor efficacy of doxorubicin. Doxorubicin hydrochloride is a water-soluble drug, which makes it difficult to physically load doxorubicin into nanoparticles in sufficient amounts.